BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32931866)

  • 1. Trends in Use of Hypofractionated Whole Breast Radiation in Breast Cancer: An Analysis of the National Cancer Database.
    Woodward SG; Varshney K; Anne PR; George BJ; Willis AI
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):449-457. PubMed ID: 32931866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis.
    Diwanji TP; Molitoris JK; Chhabra AM; Snider JW; Bentzen SM; Tkaczuk KH; Rosenblatt PY; Kesmodel SB; Bellavance EC; Cohen RJ; Cheston SB; Nichols EM; Feigenberg SJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):445-453. PubMed ID: 28639030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
    Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
    Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoption of hypofractionated whole-breast irradiation for early-stage breast cancer: a National Cancer Data Base analysis.
    Wang EH; Mougalian SS; Soulos PR; Rutter CE; Evans SB; Haffty BG; Gross CP; Yu JB
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):993-1000. PubMed ID: 25149661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
    Laucis AM; Jagsi R; Griffith KA; Dominello MM; Walker EM; Abu-Isa EI; Dilworth JT; Vicini F; Kocheril PG; Browne CH; Mietzel MA; Moran JM; Hayman JA; Pierce LJ;
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):949-958. PubMed ID: 32376311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
    Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
    Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical Implications of the Publication of Consensus Guidelines by the American Society for Radiation Oncology: Accelerated Partial Breast Irradiation and the National Cancer Data Base.
    Shaitelman SF; Lin HY; Smith BD; Shen Y; Bedrosian I; Marsh GD; Bloom ES; Vicini FA; Buchholz TA; Babiera GV
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):338-48. PubMed ID: 26853342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal impact of the publication of guidelines and randomised evidence on the adoption of hypofractionated whole breast radiotherapy for early-stage breast cancer.
    Jung KYK; Shadbolt B; Rezo A
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):530-537. PubMed ID: 31087640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer.
    Lautner M; Lin H; Shen Y; Parker C; Kuerer H; Shaitelman S; Babiera G; Bedrosian I
    JAMA Surg; 2015 Aug; 150(8):778-86. PubMed ID: 26083835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Adjuvant Radiation Therapy Is Effective for Patients With Lymph Node-Positive Breast Cancer: A Population-Based Analysis.
    Koulis TA; Nichol AM; Truong PT; Speers C; Gondara L; Tyldesley S; Lohrisch C; Weir L; Olson RA
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1150-1158. PubMed ID: 32721421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most patients are eligible for an alternative to conventional whole breast irradiation for early-stage breast cancer: A National Cancer Database Analysis.
    Balagamwala EH; Manyam BV; Leyrer CM; Karthik N; Smile T; Tendulkar RD; Cherian S; Radford D; Al-Hilli Z; Vicini F; Shah C
    Breast J; 2018 Sep; 24(5):806-810. PubMed ID: 29781235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis.
    Rice SR; Feigenberg SJ; Hamza M; Molitoris JK; Bentzen SM; Tkaczuk KHR; Rosenblatt PM; Bellavance EC; Nichols EM
    Breast Cancer Res Treat; 2019 Jun; 175(2):473-478. PubMed ID: 30796656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: Evidence of impact on reducing racial and socioeconomic disparities.
    Lamm R; Woodward SG; Varshney K; Lyons W; Anne PR; George BJ; Willis AI
    Surgery; 2022 Jul; 172(1):31-40. PubMed ID: 35489980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012.
    Delaney GP; Gandhidasan S; Walton R; Terlich F; Baker D; Currow D
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):266-272. PubMed ID: 27473814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the use of implantable accelerated partial breast irradiation for ductal carcinoma in situ: Implications of the recent amendments to the American Society for Radiation Oncology consensus guidelines.
    Haque W; Verma V; Haque A; Butler EB; Teh BS
    Brachytherapy; 2017; 16(2):402-408. PubMed ID: 28063816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States.
    Stokes WA; Amini A; Jackson MW; Plimpton SR; Kounalakis N; Kabos P; Rabinovitch RA; Rusthoven CG; Fisher CM
    Clin Breast Cancer; 2018 Jun; 18(3):220-228. PubMed ID: 28797765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    Bingham B; Patel CG; Shinohara ET; Attia A
    J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the use of breast-conserving therapy for Medicare beneficiaries in Virginia: clinical, geographic, and hospital characteristics.
    Elward KS; Penberthy LT; Bear H; Swartz DM; Boudreau RM; Cook SS
    Clin Perform Qual Health Care; 1998; 6(2):63-9. PubMed ID: 10180123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology.
    Leonardi MC; Maisonneuve P; Mastropasqua MG; Morra A; Lazzari R; Rotmensz N; Sangalli C; Luini A; Veronesi U; Orecchia R
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):806-13. PubMed ID: 22245196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.